IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.…
IM Cannabis Announces Intention to Complete 3:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance
IM Cannabis (NASDAQ: IMCC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 44 employees.
The shares were at 0.4999 USD on 20 November 2026, down 98.8% over 52 weeks. Its 52-week range is 0.3600 USD to 62.40 USD: the price is 99.2% below the high and 38.9% above the low.
Its market capitalisation is 921.90K USD.
IM Cannabis reports an operating margin of -21.3% and revenue down 40.2% year over year.
Its debt exceeds its cash by 12.21M CAD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.